Our Proprietary products

Biosafety: PKA products

Prekallikrein Activator
(PKA) Assay Kit - EP Method

PW301EP

Chromogenic assay for the determination of Prekallikrein Activator (PKA) in Human Blood Products and Biologicals according to the European Pharmacopoeia.

The assay can be performed as rate method or endpoint. The PKA standard and kit control are calibrated against the 3rd international standard for PKA.

Human blood products and biologicals

Prekallikrein Activator
(PKA) Assay Ig Kit - EP Method

PW302EP

Chromogenic assay for the determination of Prekallikrein Activator (PKA) in Human Immunoglobulin Products according to the European Pharmacopoeia.

The assay can be performed as rate method or endpoint. The PKA standard and kit control are calibrated against the 3rd international standard for PKA.

  • Plasma
  • Serum
  • Fractionated plasma
  • Concentrates/finished preparation with level adjusted to below 50 IU/mL by dilution in albumin.

Prekallikrein Activator
(PKA) Assay Kit

PW30100

Chromogenic assay for the determination of Prekallikrein Activator (PKA) in Human Blood Products and Biologicals according to the European Pharmacopoeia.

The assay can be performed as rate method or endpoint. The PKA standard and kit control are calibrated against the 3rd international standard for PKA.

Human blood products and biologicals

Prekallikrein Activator
(PKA) Assay Ig Kit

PW30200

Chromogenic assay for the determination of Prekallikrein Activator (PKA) in Human Immunoglobulin Products according to the European Pharmacopoeia.

The assay can be performed as rate method or endpoint. The PKA standard and kit control are calibrated against the 3rd international standard for PKA.

  • Plasma
  • Serum
  • Fractionated plasma
  • Concentrates/finished preparation with level adjusted to below 50 IU/mL by dilution in albumin.

You have questions or want more informations?

Not a member yet? Register now

You may also like

Human Prekallikrein Pool

PW30505

A lyophilized Human Prekallikrein Pool for the determination of Prekallikrein Activator (PKA) in Human Blood Products and Biologicals according to the European Pharmacopoeia.

  • 24 hours at room temperature
    (18-24 °C)
  • 72 hours at 2-8 °C
  • 6 month frozen at -20 °C

High Positive PKA Control

PW51005

A high positive control for assays of Prekallikrein Activator in biological fluids.

Low Positive PKA Control

PW52005

A borderline positive control for assays of Prekallikrein Activator in biological fluids.

en_GB
Scroll to Top